Kamada Ltd. (KMDA) News
Track canonical SquawkNews coverage tagged to KMDA, Kamada Ltd.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Kamada Posts Record Q2 Revenue
Kamada reports record Q2 revenue of $54.9M, up 23% YoY, and Adjusted EBITDA of $14.1M, up 29% YoY
EARNINGS | Aug 12, 2026, 11:27 AM UTC
L
Kamada Affirms FY2026 Sales Guidance
Kamada affirms FY2026 sales outlook of $200-205 million
EARNINGS | Aug 12, 2026, 11:07 AM UTC
L
KMDA Reports Record-High Q2 and H1 2026 Results
KMDA reports record-high Q2 and H1 2026 financial results with double-digit growth
EARNINGS | Aug 12, 2026, 11:05 AM UTC
L
KMDA Announces CFO Transition
Kamada announces planned transition of Chief Financial Officer
MNA | Aug 12, 2026, 11:00 AM UTC
L
KMDA - Kamada to Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12, 2026
KMDA - Kamada to Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12, 2026
EARNINGS | Aug 05, 2026, 11:00 AM UTC
L
KMDA +3% in pre-mkt following earlier PR: Kamada Announces a Three-Year $50M Sales Agreement to Supply Plasma to a Leading Biopharmaceutical
KMDA +3% in pre-mkt following earlier PR: Kamada Announces a Three-Year $50M Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies Through Texas Centers, Commercial S
EQUITY | Jul 20, 2026, 01:17 PM UTC